Pharming (PHAR) Non-cash Items (2020 - 2026)

Pharming (PHAR) has 7 years of Non-cash Items data on file, last reported at $46.9 million in Q4 2025.

• Quarterly Non-cash Items rose 151.09% year-over-year to $46.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $72.7 million (up 115.97% YoY) and the FY2025 annual result came in at $46.9 million, changed N/A from the prior year.
• Non-cash Items rose to $46.9 million in Q4 2025, from $18.7 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $46.9 million in Q4 2025 to a low of -$25.1 million in Q3 2021.
• A 5-year average of $6.0 million and a median of $8.4 million in 2021 frame the typical range for Non-cash Items.
• The widest YoY moves for Non-cash Items: up 9535.18% in 2021, down 190.45% in 2021.
• Tracing PHAR's Non-cash Items over 5 years: stood at $9.0 million in 2021, then plunged by 32.37% to $6.1 million in 2022, then slumped by 142.22% to -$2.6 million in 2023, then surged by 826.35% to $18.7 million in 2024, then surged by 151.09% to $46.9 million in 2025.
• The last three Non-cash Items figures came in at $46.9 million (Q4 2025), $18.7 million (Q4 2024), and $9.7 million (Q3 2024), per Business Quant data.